EcoDrugPlus

Ensembl ID : ENSAPEG00000012135
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSAPEG00000011972
Gene Symbol: -
Cross references: -
91 Possible Orthologues:

Ensembl ID : ENSAPEG00000011554
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSAPEG00000005514
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSAPEG00000009272
Gene Symbol: -
Cross references: -
104 Possible Orthologues:

Ensembl ID : ENSAPEG00000005064
Gene Symbol: VEGFAA
1 Cross references
181 Possible Orthologues:

Ensembl ID : ENSAPEG00000003932
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSAPEG00000009615
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSAPEG00000004225
Gene Symbol: RPS21
1 Cross references
301 Possible Orthologues:

Ensembl ID : ENSAPEG00000009646
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSAPEG00000003979
Gene Symbol: SIGMAR1
1 Cross references
205 Possible Orthologues:

Ensembl ID : ENSAPEG00000003530
Gene Symbol: RPLP0
1 Cross references
403 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).